Absenteeism
School dropout and conduct disorder in Brazilian elementary school students (Tramontina S, Martins S, Michalowski MB, Ketzer CR, Eizirik M, Biederman J, Rohde LA) (941)

acute psychiatric wards
Crowding and violence on psychiatric wards: explanatory models (Kumar S, Ng B) (433)

acute stress
Peritraumatic dissociation, acute stress, and early posttraumatic stress disorder in victims of general crime (Birmes P, Carreras D, Ducassé J-L, Charlet J-P, Warner BA, Lauque D, Laurent Schmitt L) (649)

addictions
Physical and sexual abuse issues among youths with substance use problems (Ballon BC, Courbasson CMA, Smith PD) (617)

administration de la santé
« What’s up, doc? » Le contexte, les limites et les enjeux de la médecine fondée sur des données probantes pour les cliniciens (evidence-based medicine) (Lesage AD, Stip E, Grunberg F) (396)

adolescence Antidepressant-induced sexual dysfunction in adolescent [letter] (Robinson MJ) (185)

The pharmacologic treatment of the early phase of first-episode psychosis in youths (Walter G, Wiltshire C, Anderson J, Storm V) (803)

Frequency of borderline personality disorder in a sample of French high school students (Chabrol H, Montovany A, Chouicha K, Callahan S, Mullet E) (847)

adolescent
Evaluation of droperidol in the acutely agitated child or adolescent [letter] (Hameer O, Collin K, Ensom MHH, Lomax S) (864)

Left medial temporal cytosolic choline in early onset depression (Kusumakar V, MacMaster FP, Gates L, Sparkes SJ, Khan SC) (959)

Électroconvulsivothérapie chez l’adolescent : considérations cliniques à propos d’une série d’observations (Étain B, Le Heuzey M-F, Mouren-Simeoni M-C) (976)

adolescent psychiatric inpatient unit
Consumer satisfaction with an adolescent inpatient psychiatric unit (Marriage K, Petrie P, Worling D) (969)

adolescents
A family study of juvenile obsessive-compulsive disorder (Reddy PS, Reddy YCJ, Srinath S, Khanna S, Sheshadri SP, Girimaji SR) (346)

Open-label risperidone treatment of 6 children and adolescents with autism [letter] (Vercellino F, Zanotto E, Ravera G, Veneselli E) (559)

The use of electroconvulsive therapy in special patient populations (Rabheru K) 710

Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities (Friedlander RB, Lazar S, Klancnik J) (741)

Adolescents with psychiatric disorders:when to treat? And with what? [editorial] Duffy A (795)

Suicide in adolescents in Italy (1969-1994) [letter] (Mancinelli I, Ceciarelli L, Comparelli A, Lazanio S, Girardi P, Tatarelli R) (862)

adoption
Why are children in the same family so different? Nonshared environment a decade later (Plomin R, Asbury K, Dunn J) (225)

adverse drug reaction
Adverse reactions to St John’s wort (Parker V, Wong AHC, Boon HS, Seeman MV) (77)

Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors (SSRIs)? (Dalfen AK, Devarajan S Stewart DE) (258)

aggression
The neuropsychopharmacology of criminality and aggression (Lee R) (35)

Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset schizophrenia (Chalasani L, Kant R, KN Roy Chengappa KNR) (965)

agoraphobia
Separation anxiety and actual separation experiences during childhood in patients with panic disorder (Bandelow B, Alvarez Tichauer GA, Späth C, Broocks A, Hajak G, MD5, Bleich S, Rüther E) (948)

AIDS
The effect of divalproex sodium on viral load: a retrospective review of HIV-positive patients with manic syndromes (Maggi JD Halman MH) (359)

alcohol abuse
Polydipsia, Psychosis, and Familial Psychopathology (Ahmed AG, Heigh LM, Ramachandran KV) (522)

Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

alcohol consumption
A prospective study of sex-specific effects of major depression on alcohol consumption (Wang J, Patten SB) (422)

Alcohol consumption and major depression: findings from a follow-up study (Wang J, Patten SB) (632)

alcoholism
A social problem index for Canada (Thompson AH, Howard AW, Jin Y) (45)

Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

alternative medicine
Alcoholism: beliefs and attitudes among Canadian alcoholism treatment practitioners (Meza EE, Cunningham JA, el-Guebaly N, Couper L) (167)

Alternative medicine use by individuals with major depression (Wang J, Patten SB, Russell ML) (528)

amygdala
Left medial temporal cytosolic choline in early onset depression (Kusumakar V, MacMaster FP, Gates L, Sparkes SJ, Khan SC) (959)

anorexia
Severe anorexia in an Amish Mennonite teenager [letter] (Husni M, Koye N, Haggarty J) (183)

antiandrogens
The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour (Bradford JMW) (26)

antidepressant
Adverse reactions to St John’s wort (Parker V, Wong AHC, Boon HS, Seeman MV) (77)

antidepressants
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Antidepressant-induced sexual dysfunction in adolescent [letter] (Robinson MJ) (185)

Are newer antidepressants really “better tolerated”? [letter] (Robinson MJ) (286)

antidépresseurs
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

antipsychotics
Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution (Procyshyn RM, Kennedy NB, Tse G, Thompson B) (334)

Risperidone Treatment of Outpatients With Schizophrenia: No Evidence of Sex Differences in Treatment Response (Labelle A, Light M, Dunbar F) (534)

Re: weight change with antipsychotic use [letter] (Dewan VK) (660)

antisocial behaviour
Effective interventions for children and adolescents with conduct disorder (Frick PJ) (597)

Neuroimaging studies of antisocial behaviour (Bassarath L) (728)

anxiety
Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

anxiety disorders
Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity (Masi A, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS) (797)

appetite suppressants
“Diet pills” and major depression in the Canadian population (Patten SB) (438)

aspects culturels
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

assertive community treatment
Global assessment of functioning following assertive community treatment in Edmonton, Alberta: a longitudinal study (Tibbo P, Joffe K, Chue P, Metelitsa A, Wright E) (144)

Re: using global assessment of functioning to evaluate an assertive community treatment program [letter] (Malla A) (986)

Using global assessment of functioning to evaluate an assertive community treatment program: reply [letter] (Chue PS) (986)

athymhormie
Le concept français d’athymhormie de 1922 à nos jours (Luauté J-P, Saladini O) (639)

attachment
Individual predictors of posttraumatic distress: a structural equation model (Regehr C, Hemsworth D, Hill J) (156)

attention-deficit hyperactivity disorder
Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates (Brownell MD, Yogendran MS) (264)

Pre-, peri-, and postnatal trauma in subjects with attention-deficit hyperactivity disorder (Zappitelli M, Pinto T, Grizenko N) (542)

Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results (Rowland AS, Umbach DM, Catoe KE, Stallone L, Long S, Rabiner D, Naftel AJ, Panke D, Faulk R, Sandler DP) (931)

attitudes
Educating the public about mental illness and homelessness: a cautionary note (Tolomiczenko GS, Goering PN, Durbin JF) (253)

atypical antipsychotics
Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities (McIntyre RS McCann SM, Kennedy SH) (273)

Atypical antipsychotics and neuroleptic malignant syndrome [letter] (Velamoor VR) (865)

Reply: atypical antipsychotics and neuroleptic malignant syndrome [letter] (Biancosino B, Grassi L) (866)

The evolving clinical profile of atypical antipsychotic medications [letter] (Buckley PF, Miller DD, Singer B, Donenwirth K) (285)

atypical neuroleptics
Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities (Friedlander RB, Lazar S, Klancnik J) (741)

augmentation
Lithium revisited (McIntyre RS, Mancini DA, Parikh S, Kennedy SH) (322)

autism
Open-label risperidone treatment of 6 children and adolescents with autism [letter] (Vercellino F, Zanotto E, Ravera G, Veneselli E) (559)

C

catatonie
Électroconvulsivothérapie chez l’adolescent : considérations cliniques à propos d’une série d’observations (Étain B, Le Heuzey M-F, Mouren-Simeoni M-C) (976)

cellular phone
Does the cellular phone help to communicate when face-to-face contracts are difficult? [letter] (Honkalampi K, Tanskanen A, Hintikka J, Haatainen K, Viinamäki H) (373)

cerebral glucose metabolism
Regional cerebral glucose metabolism in never-medicated patients with schizophrenia (Clark C, Kopala L, Li DK, Hurwitz T) (340)

change
Change: chaos or challenge? [editorial] (Rae-Grant Q) (22)

change scores
Regression toward the mean: its etiology, diagnosis, and treatment (Streiner DL) (72)

child
Evaluation of droperidol in the acutely agitated child or adolescent [letter] (Hameer O, Collin K, Ensom MHH, Lomax S) (864)

child psychiatry
Conduct disorder: a challenge to child psychiatry [editorial] (Shamsie J) (593)

The science of child psychiatry [editorial] (Schachar R) (915)

childhood anxiety disorders
Correlation between anxiety and oppositionality in a children’s mood and anxiety disorder clinic (Garland EJ, Garland OM) (953)

childhood-onset schizophrenia
Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset schizophrenia (Chalasani L, Kant R, KN Roy Chengappa KNR) (965)

children
A family study of juvenile obsessive-compulsive disorder (Reddy PS, Reddy YCJ, Srinath S, Khanna S, Sheshadri SP, Girimaji SR) (346)

Open-label risperidone treatment of 6 children and adolescents with autism [letter] (Vercellino F, Zanotto E, Ravera G, Veneselli E) (559)

The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results (Rowland AS, Umbach DM, Catoe KE, Stallone L, Long S, Rabiner D, Naftel AJ, Panke D, Faulk R, Sandler DP) (931)

Childhood-onset schizophrenia: research update (Kumra S, Shaw M, Merka P, Nakayama E, Augustin R) (923)

children and adolescents
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

chloral hydrate
Fatal chloral hydrate overdoses: unnecessary tragedies [letter] (Frankland A, Robinson MJ) (763)

cholesterol
Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder (Sevincok L, Buyukozturk A, Dereboy F) (68)

choline
Left medial temporal cytosolic choline in early onset depression (Kusumakar V, MacMaster FP, Gates L, Sparkes SJ, Khan SC) (959)

chronic depression
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

chronic mentally ill
Global assessment of functioning following assertive community treatment in Edmonton, Alberta: a longitudinal study (Tibbo P, Joffe K, Chue P, Metelitsa A, Wright E) (144)

citalopram overdose
Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? [letter] (Isbister GK, Dawson A, Whyte IM) (657)

Reply: citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? (Aydin N, Anaç A, Çayköylü A, Akçay F) [letter] (658)

Clerambault’s syndrome
The misidentification of Clerambault’s and Kandinsky-Clerambault’s syndromes (Lerner V, Kaptsan A, Witztum E) (441)

clinical guidelines
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Re: clinical guidelines for the treatment of depressive disorders [letter] (Ney P) (987)

clinical listening
Using language in psychiatry (Fine J) (916)

clinical medicine
Recent advances in evidence-based psychiatry (Geddes J, Carney S) (403)

clinical outcome
Consumer satisfaction with an adolescent inpatient psychiatric unit (Marriage K, Petrie P, Worling D) (969)

clinical trials
Clinical trials in psychiatry: do results apply to practice? (Seeman MV) (352)

clozapine
Suspected neuroleptic catatonia induced by clozapine [letter] (Biancosino B, Zanchi P, Agostini M, Grassi L) (458)

Clozapine impact on clinical outcomes and aggression in severely ill adolescents with childhood-onset schizophrenia (Chalasani L, Kant R, KN Roy Chengappa KNR) (965)

cognitive errors
Epidemiology of problem gambling in Prince Edward Island: a Canadian microcosm? (Doiron JP, Nicki RM) (413)

combination drug therapy
Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study (Francobandiera G) (356)

committal criteria
Clinically significant differences among Canadian mental health acts (Gray JE, O’Reilly RL) (315)

community treatment orders
Clinically significant differences among Canadian mental health acts (Gray JE, O’Reilly RL) (315)

community psychiatry
Re: training residents for community psychiatric practice the resident perspective [letter] (Conlon P) (561)

comorbidité
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

comorbidity
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

compulsions
Obsessive compulsive disorder and psychosis (Ganesan V, Kumar TCR, Khanna S) (750)

compulsive sexual behaviour
The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour (Bradford JMW) (26)

Re: the neurobiology, neuropharmacology, and pharmacologic treatment of paraphilias and compulsive sexual behaviour [letter] (Haslam D, Adams S, Oluboka O) (559)

conduct disorder
Conduct disorder: a challenge to child psychiatry [editorial] (Shamsie J) (593)

Effective interventions for children and adolescents with conduct disorder (Frick PJ) (597)

Conduct disorder: a biopsychosocial review (Bassarath L) (609)

School dropout and conduct disorder in Brazilian elementary school students (Tramontina S, Martins S, Michalowski MB, Ketzer CR, Eizirik M, Biederman J, Rohde LA) (941)

consumer satisfaction
Consumer satisfaction with an adolescent inpatient psychiatric unit (Marriage K, Petrie P, Worling D) (969)

conventional antipsychotics
Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities (McIntyre RS McCann SM, Kennedy SH) (273)

costs
Economic impacts of supported employment for persons with severe mental illness (Latimer EA) (496)

cost-effectiveness
Economic impacts of supported employment for persons with severe mental illness (Latimer EA) (496)

crime
A social problem index for Canada (Thompson AH, Howard AW, Jin Y) (45)

criminal harassment
Criminal harassment by patients with mental disorders (Adams SJ, Pitre NL, Smith A) (173)

criminality
The neuropsychopharmacology of criminality and aggression (Lee R) (35)

critical incidents
Individual predictors of posttraumatic distress: a structural equation model (Regehr C, Hemsworth D, Hill J) (156)

Crohn’s disease
Supportive-expressive group psychotherapy for inflammatory bowel disease (Maunder RG, Esplen MJ) (622)

cross-sectional studies
“Diet pills” and major depression in the Canadian population (Patten SB) (438)

crowding
Crowding and violence on psychiatric wards: explanatory models (Kumar S, Ng B) (433)

cultural issues
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

D

early intervention
Treating psychosis: is there more to early intervention than intervening early? (Malla AM, Norman RMG) (645)

early psychosis
The pharmacologic treatment of the early phase of first-episode psychosis in youths (Walter G, Wiltshire C, Anderson J, Storm V) (803)

economics
Economic impacts of supported employment for persons with severe mental illness (Latimer EA) (496)

edema
Risperidone-induced edema [letter] (Ravasia S) 453

education program
Educating the public about mental illness and homelessness: a cautionary note (Tolomiczenko GS, Goering PN, Durbin JF) (253)

efficacité
Électroconvulsivothérapie chez l’adolescent : considérations cliniques à propos d’une série d’observations (Étain B, Le Heuzey M-F, Mouren-Simeoni M-C) (976)

efficacy
Lithium revisited (McIntyre RS, Mancini DA, Parikh S, Kennedy SH) (322)

elderly
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

Psychosocial risk factors in poststroke depression: a systematic review (Ouimet MA, Primeau F, Cole MG) (819)

electroconvulsive therapy
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Electroconvulsive therapy: the controversy and the evidence [editorial] (Persad E) (702)

Electroconvulsive therapy’s effect on suicide risk in patients with mood disorders (Sharma V) (704)

The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

Transcranial magnetic stimulation in the treatment of mood disorder: a review and comparison with electroconvulsive therapy (Hasey G) (720)

Electroconvulsive therapy in cases of treatment-resistant psychosis [letter] (Parker V, Remington G) (762)

électroconvulsivothérapie
Électroconvulsivothérapie chez l’adolescent : considérations cliniques à propos d’une série d’observations (Étain B, Le Heuzey M-F, Mouren-Simeoni M-C) (976)

emotion
Factorial structure of the sensation-seeking scale-form V: confirmatory factorial analyses in nonclinical and clinical samples (Loas G, Verrier A, Flament MF, Perez-Diaz F, Corcos M, Halfon O, Lang F, Bizouard P, Venisse J-L, Guelfi JD, Jeammet P) (850)

enseignement médical
« What’s up, doc? » Le contexte, les limites et les enjeux de la médecine fondée sur des données probantes pour les cliniciens (evidence-based medicine) (Lesage AD, Stip E, Grunberg F) (396)

environment
Behavioural genetic perspectives on personality function (Jang KL Vernon PA, Livesley WJ) (234)

environmental stress
Crowding and violence on psychiatric wards: explanatory models (Kumar S, Ng B) (433)

épidémiologie génetique
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

epidemiology
Is schizophrenia on the decline in Canada? (Woogh C) 61

Delirium in psychiatric inpatients: a case-control study (Patten SB, Williams JVA, Petcu R, Oldfield R) (162)

“Diet pills” and major depression in the Canadian population (Patten SB) (438)

Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results (Rowland AS, Umbach DM, Catoe KE, Stallone L, Long S, Rabiner D, Naftel AJ, Panke D, Faulk R, Sandler DP) (931)

eponyms
The misidentification of Clerambault’s and Kandinsky-Clerambault’s syndromes (Lerner V, Kaptsan A, Witztum E) (441)

erotomania
The misidentification of Clerambault’s and Kandinsky-Clerambault’s syndromes (Lerner V, Kaptsan A, Witztum E) (441)

étiologie
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

evidence-based medicine
Recent advances in evidence-based psychiatry (Geddes J, Carney S) (403)

evidence-based psychiatry
Evidence-based psychiatry: the pros and cons [editorial] (Dongier M) 394

externalizing disorders
Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity (Masi A, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS) (797)

extrapyramidal symptoms
Risperidone Treatment of Outpatients With Schizophrenia: No Evidence of Sex Differences in Treatment Response (Labelle A, Light M, Dunbar F) (534)

F

familial
A family study of juvenile obsessive-compulsive disorder (Reddy PS, Reddy YCJ, Srinath S, Khanna S, Sheshadri SP, Girimaji SR) (346)

families
Why are children in the same family so different? Nonshared environment a decade later (Plomin R, Asbury K, Dunn J) (225)

fee-for-service
Using financial incentives to promote shared mental health care (Dewa CS, Hoch JS, Goering P) (488)

fenfluramine
The neuropsychopharmacology of criminality and aggression (Lee R) (35)

fibromyalgia
Tryptophan for treatment of rapid-cycling bipolar disorder comorbid with fibromyalgia [letter] (Sharma V, Barrett C) (452)

financial incentives
using financial incentives to promote shared mental health care (Dewa CS, Hoch JS, Goering P) (488)

first episode
Social functioning in first- and multiepisode schizophrenia (Grant C, Addington J, Addington D, Konnert C) (746)

first-onset psychosis
The pharmacologic treatment of the early phase of first-episode psychosis in youths (Walter G, Wiltshire C, Anderson J, Storm V) (803)

first-degree relatives
Polydipsia, psychosis, and familial psychopathology (Ahmed AG, Heigh LM, Ramachandran KV) (522)

fitness to stand trial
Assessing fitness to stand trial: the utility of the fitness interview test (Revised Edition) (Zapf PA, Roesch R, Viljoen JL) (426)

Fitness Interview Test
Assessing fitness to stand trial: the utility of the Fitness Interview Test (Revised Edition) (Zapf PA, Roesch R, Viljoen JL) (426)

fluoxetine
Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action? [letter] (Dursun SM) (287)

fluvoxamine
Case of resistant trichotillomania treated with risperidone-augmented fluvoxamine [letter] (Gabriel A A) (285)

fonctionnement social
Validation de la version française du health of the nation outcome scales (HoNOS-F) (Lauzon S, Corbière M, Bonin J-P, Bonsack C, Lesage AD, Ricard N) (841)

forensic assessment
Assessing fitness to stand trial: the utility of the fitness interview test (revised edition) (Zapf PA, Roesch R, Viljoen JL) (426)

frail elderly
The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

frequency
Frequency of borderline personality disorder in a sample of French high school students (Chabrol H, Montovany A, Chouicha K, Callahan S, Mullet E) (847)

functional linguistics
Using language in psychiatry (Fine J) (916)

G

global assessment of
functioning (cont'd)
Using global assessment of functioning to evaluate an assertive community treatment program: reply [letter] (Chue PS) (986)

gonadal steroids
Antipsychotic drugs and obesity: is prolactin involved? (Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejìas MA, Hernàndez L) (829)

Griffin, John Douglas Morecroft In memoriam: John Douglas Morecroft Griffin (Greenland C, Kajander R) (595)

group psychotherapy
Supportive-expressive group psychotherapy for inflammatory bowel disease (Maunder RG, Esplen MJ) (622)

guide de pratique clinique
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

guidelines
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Recent advances in evidence-based psychiatry (Geddes J, Carney S) (403)

H

impulsiveness
The neuropsychopharmacology of criminality and aggression (Lee R) (35)

index
A social problem index for Canada (Thompson AH, Howard AW, Jin Y) (45)

individual difference
Clinical trials in psychiatry: do results apply to practice? (Seeman MV) (352)

individual placement and support
Economic impacts of supported employment for persons with severe mental illness (Latimer EA) (496)

inflammatory bowel disease
Supportive-expressive group psychotherapy for inflammatory bowel disease (Maunder RG, Esplen MJ) (622)

information systems
Recent advances in evidence-based psychiatry (Geddes J, Carney S) (403)

inositol
Mania associated with an energy drink: the possible role of caffeine, taurine, and inositol [letter] (Machado-Vieira R, Viale CI, Kapczinski F) (454)

inpatient morbidity
Using databases to prevent inpatient morbidity [letter] (Bristow K, Patten S) (455)

insulin sensitivity
Antipsychotic drugs and obesity: is prolactin involved? (Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejìas MA, Hernàndez L) (829)

intentional overdose
Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors (SSRIs)? (Dalfen AK, Devarajan S Stewart DE) (258)

interaction
Using language in psychiatry (Fine J) (916)

interactions médicamenteuses
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Internet
“Internet delusion” in a patient with a schizoaffective disorder [letter] (Kobayashi T, Okada Y, Nisijima K, Kato S) (89)

« What’s up, doc? » Le contexte, les limites et les enjeux de la médecine fondée sur des données probantes pour les cliniciens (evidence-based medicine) (Lesage AD, Stip E, Grunberg F) (396)

intravenous
The Use of Intravenous Valproate in Psychiatry [letter] (Norton J) (371)

job satisfaction
Predictors of success and satisfaction in the practice of psychiatry: a preliminary follow-up study (Garfinkel PE, Bagby RM, Schuller DR, Williams CC, Dickens SE, Dorian B) (835)

Kandinsky-Clerambault’s syndrome
The misidentification of Clerambault’s and Kandinsky-Clerambault’s syndromes (Lerner V, Kaptsan A, Witztum E) (441)

labour complications
Pre-, peri-, and postnatal trauma in subjects with attention-deficit hyperactivity disorder (Zappitelli M, Pinto T, Grizenko N) (542)

lamotrigine
Lamotrigine: a review of clinical studies in bipolar disorders (Zerjav-Lacombe S, Tabarsi E) (328)

language
Discourse characteristics of subjects with schizophrenia and prominent negative symptoms [letter] (Noel-Jorand MC, Giudicelli S, Dassa D) (761)

Using language in psychiatry (Fine J) (916)

laryngeal dystonia
Laryngeal dystonia in psychiatry [letter] (Norton J) 453

LHRH agonists
The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour (Bradford JMW) (26)

liaison génétique
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

lifestyle
Predictors of success and satisfaction in the practice of psychiatry: a preliminary follow-up study (Garfinkel PE, Bagby RM, Schuller DR, Williams CC, Dickens SE, Dorian B) (835)

L cont'd

light therapy
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

limbic system
Neuroimaging studies of antisocial behaviour (Bassarath L) (728)

linkage
Genetic insights into schizophrenia (Bassett AS, Chow EWC, Waterworth DM, Brzustowicz L) (131)

lithium
Lithium revisited (McIntyre RS, Mancini DA, Parikh S, Kennedy SH) (322)

low-density lipoprotein cholesterol
Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder (Sevincok L, Buyukozturk A, Dereboy F) (68)

lycanthropy
Lycanthropy: 2 case reports [letter] (Gödecke-Koch T, Garlipp P, Haltenhof H, Dietrich DE) (659)

magnetic resonance imaging
Neuroimaging studies of antisocial behaviour (Bassarath L) (728)

magnetic resonance spectroscopy
Left medial temporal cytosolic choline in early-onset depression (Kusumakar V, MacMaster FP, Gates L, Sparkes SJ, Khan SC) (959)

maintenance therapy
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

major depression
A prospective study of sex-specific effects of major depression on alcohol consumption (Wang J, Patten SB) (422)

Alternative medicine use by individuals with major depression (Wang J, Patten SB, Russell ML) (528)

Alcohol consumption and major depression: findings from a follow-up study (Wang J, Patten SB) (632)

major depressive disorder
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder (Sevincok L, Buyukozturk A, Dereboy F) (68)

management
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

mania
The effect of divalproex sodium on viral load: a retrospective review of HIV-positive patients with manic syndromes (Maggi JD Halman MH) (359)

Mania associated with an energy drink: the possible role of caffeine, taurine, and inositol [letter] (Machado-Vieira R, Viale CI, Kapczinski F) (454)

Gabapentin as a prophylaxis against steriod-induced mania [letter] (Ginsberg DL, Sussman N) (455)

medical informatics
Recent advances in evidence-based psychiatry (Geddes J, Carney S) (403)

medically ill
The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

medication
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

mental disorder
Criminal harassment by patients with mental disorders (Adams SJ, Pitre NL, Smith A) (173)

mental health acts
Clinically significant differences among Canadian mental health acts (Gray JE, O’Reilly RL) (315)

mental health promotion
Community attitudes toward people with schizophrenia (Stuart H, Arboleda-Flórez J) (245)

mental automatism
The misidentification of Clerambault’s and Kandinsky-Clerambault’s syndromes (Lerner V, Kaptsan A, Witztum E) (441)

mental health policy
The contributions of health economics to mental health policy [editorial] (Gnam WH) (486)

mental illness
Educating the public about mental illness and homelessness: a cautionary note (Tolomiczenko GS, Goering PN, Durbin JF) (253)

Economic impacts of supported employment for Persons With Severe Mental Illness (Latimer EA) (496)

mental retardation
Developmental disability training in Canadian psychiatry residency programs (Lunsky Y, Bradley E) (138)

Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities (Friedlander RB, Lazar S, Klancnik J) (741)

méta-analyses
« What’s up, doc? » Le contexte, les limites et les enjeux de la médecine fondée sur des données probantes pour les cliniciens (evidence-based medicine) (Lesage AD, Stip E, Grunberg F) (396)

methods
Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results (Rowland AS, Umbach DM, Catoe KE, Stallone L, Long S, Rabiner D, Naftel AJ, Panke D, Faulk R, Sandler DP) (931)

méthodes diagnostiques
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

methylphenidate
Obsessive-compulsive symptoms secondary to methylphenidate treatment [letter] (Kotsopoulos S, Spivak M) (89)

metoclopramide
Ondansetron rather than metoclopramide for bupropion-induced nausea [letter] (Lara DR, Busnello ED, Souza DO) (371)

Modified Mini-Mental State Examination
Mild dementia or cognitive impairment: the modified mini-mental state examination (3MS) as a screen for dementia (Bland RC, Newman SC) (506)

molecular genetics
Behavioural genetic perspectives on personality function (Jang KL Vernon PA, Livesley WJ) (234)

mood stabilizers
Treatment of mixed mania with risperidone and mood stabilizers [letter] (Benabarre A, Vieta E, Colom F, Martinez A, Reinares M, Corbella B) (866)

mood disorders
Electroconvulsive therapy’s effect on suicide risk in patients with mood disorders (Sharma V) (704)

mothers
Moving from the clinic to the community: the alone mothers together program [letter] (Lipman EL, Secord M, Boyle MH) (657)

motivation
Le concept français d’athymhormie de 1922 à nos jours (Luauté J-P, Saladini O) (639)

multiple regression
Epidemiology of problem gambling in Prince Edward Island: a Canadian microcosm? (Doiron JP, Nicki RM) (413)

nausea
Ondansetron rather than metoclopramide for bupropion-induced nausea [letter] (Lara DR, Busnello ED, Souza DO) (371)

negative symptoms
Discourse characteristics of subjects with schizophrenia and prominent negative symptoms [letter] (Noel-Jorand MC, Giudicelli S, Dassa D) (761)

neuroimaging
Childhood-onset schizophrenia: research update (Kumra S, Shaw M, Merka P, Nakayama E, Augustin R) (923)

neuroleptic
Sudden death following neuroleptic administration due to hemoperitoneum resulting from physical restraint [letter] (Raju GVL, Ramesh Kumar TC, Khanna S) (372)

neuroleptic catatonia
Suspected neuroleptic catatonia induced by clozapine [letter] (Biancosino B, Zanchi P, Agostini M, Grassi L) (458)

neuroleptic malignant syndrome
Neuroleptic malignant syndrome associated with quetiapine [letter] (Karagianis J, Phillips L, Hogan K, LeDrew K) (370)

Neuroleptic malignant syndrome associated with quetiapine: a response [letter] (Al-Waneen R) (370)

Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? [letter] (Isbister GK, Dawson A, Whyte IM) (657)

Reply: citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? (Aydin N, Anaç A, Çayköylü A, Akçay F) [letter] (658)

Atypical antipsychotics and neuroleptic malignant syndrome [letter] (Velamoor VR) (865)

Reply: atypical antipsychotics and neuroleptic malignant syndrome [letter] (Biancosino B, Grassi L) (866)

neuroprotective
Developmental neurobiology: implications for pediatric psychopharmacology (Carrey N) (810)

neuropsychiatrie
Le concept français d’athymhormie de 1922 à nos jours (Luauté J-P, Saladini O) (639)

neurotoxic
Developmental neurobiology: implications for pediatric psychopharmacology (Carrey N) (810)

nonresponders
Lamotrigine: a review of clinical studies in bipolar disorders (Zerjav-Lacombe S, Tabarsi E) (328)

nonshared environment
Why are children in the same family so different? Nonshared environment a decade later (Plomin R, Asbury K, Dunn J) (225)

obesity
Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities (McIntyre RS McCann SM, Kennedy SH) (273)

Body mass index in persons with schizophrenia (Coodin S) (549)

O cont'd

obesity (cont'd)
Antipsychotic drugs and obesity: is prolactin involved? (Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejìas MA, Hernàndez L) (829)

obesity comorbidity
Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities (McIntyre RS McCann SM, Kennedy SH) (273)

obsessions
Obsessive compulsive disorder and psychosis (Ganesan V, Kumar TCR, Khanna S) (750)

obsessive-compulsive disorder
Obsessive-compulsive symptoms secondary to methylphenidate treatment [letter] (Kotsopoulos S, Spivak M) (89)

A family study of juvenile obsessive-compulsive disorder (Reddy PS, Reddy YCJ, Srinath S, Khanna S, Sheshadri SP, Girimaji SR) (346)

Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study (Francobandiera G) (356)

olanzapine
Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal [letter] (Llorca P-M, Vaiva G, Lancon C) (87)

Treatment of posttraumatic stress disorder with olanzapine [letter] (Prior TI) (182)

Re: Treatment of posttraumatic stress disorder with olanzapine [letter] (Labbate LA, Douglas S) (182)

Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study (Francobandiera G) (356)

Olanzapine-related hyperglycemia in a nondiabetic woman [letter] (Kropp S, Emrich HM, Bleich S, Degner D) (457)

olfaction
Regional cerebral glucose metabolism in never-medicated patients with schizophrenia (Clark C, Kopala L, Li DK, Hurwitz T) (340)

ondansetron
Ondansetron rather than metoclopramide for bupropion-induced nausea [letter] (Lara DR, Busnello ED, Souza DO) (371)

Ontario Health Survey
Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

oppositional defiant disorder
Correlation between anxiety and oppositionality in a children’s mood and anxiety disorder clinic (Garland EJ, Garland OM) (953)

organic mental disorder
Delirium in psychiatric inpatients: a case-control study (Patten SB, Williams JVA, Petcu R, Oldfield R) (162)

outpatient clinic
Home visits from an outpatient psychiatric clinic [letter] (Moldavsky D, Szor H, Melamed Y, Levi D, Elizur A) (562)

overdose
Fatal chloral hydrate overdoses: unnecessary tragedies [letter] (Frankland A, Robinson MJ) (763)

panic disorder
Separation anxiety and actual separation experiences during childhood in patients with panic disorder (Bandelow B, Alvarez Tichauer GA, Späth C, Broocks A, Hajak G, MD5, Bleich S, Rüther E) (948)

paraphilias
The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour (Bradford JMW) (26)

Re: the neurobiology, neuropharmacology, and pharmacologic treatment of paraphilias and compulsive sexual behaviour [letter] (Haslam D, Adams S, Oluboka O) (559)

parkinsonism
Bupropion and drug-induced parkinsonism [letter] (Jerome L) (560)

paroxetine
Galactorrhea induced by paroxetine [letter] (Morrison J, Remick RA, Leung M, Wrixon KJ, Bebb RA) (88)

pathological aggression
Neuropsychopharmacology of pathological aggression and sexuality [guest editorial] (Keegan DL) (24)

pathological gambling
Epidemiology of problem gambling in Prince Edward Island: a Canadian microcosm? (Doiron JP, Nicki RM) (413)

A profile of Canadian adults seeking treatment for gambling problems and comparisons with adults entering an alcohol treatment program (Wiebe J, Cox BJ) (418)

pediatric psychopharmacology
Developmental neurobiology: implications for pediatric psychopharmacology (Carrey N) (810)

pénétrance
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

perfectionism
The phenomenology of perfectionism: “yumpity”[letter] (Bilsbury C, Tang M, Bilsbury J) (863)

perinatal
Pre-, peri-, and postnatal trauma in subjects with attention-deficit hyperactivity disorder (Zappitelli M, Pinto T, Grizenko N) (542)

peritraumatic dissociation
Peritraumatic dissociation, acute stress, and early posttraumatic stress disorder in victims of general crime (Birmes P, Carreras D, Ducassé J-L, Charlet J-P, Warner BA, Lauque D, Laurent Schmitt L) (649)

personality
Behavioural genetic perspectives on personality function (Jang KL Vernon PA, Livesley WJ) (234)

Predictors of success and satisfaction in the practice of psychiatry: a preliminary follow-up study (Garfinkel PE, Bagby RM, Schuller DR, Williams CC, Dickens SE, Dorian B) (835)

personality disorder
Behavioural genetic perspectives on personality function (Jang KL Vernon PA, Livesley WJ) (234)

perte d’auto-activation psychique
Le concept français d’athymhormie de 1922 à nos jours (Luauté J-P, Saladini O) (639)

pharmacochallenge
The neuropsychopharmacology of criminality and aggression (Lee R) (35)

pharmacologic hypomania
Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity (Masi A, Toni C, Perugi G, Mucci M, Millepiedi S, Akiskal HS) (797)

pharmacologic treatment
The pharmacologic treatment of the early phase of first-episode psychosis in youths (Walter G, Wiltshire C, Anderson J, Storm V) (803)

pharmacothérapie
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

pharmacotherapy
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Alcoholism: beliefs and attitudes among Canadian alcoholism treatment practitioners (Meza EE, Cunningham JA, el-Guebaly N, Couper L) (167)

phénotype
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

phobia
Comorbidity of phobic disorders with alcoholism in a Canadian community sample (Sareen J, Chartier M, Kjernisted KD, Stein MB) (733)

photothérapie
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

physical abuse
Physical and sexual abuse issues among youths with substance use problems (Ballon BC, Courbasson CMA, Smith PD) (617)

polydipsia
Polydipsia, Psychosis, and Familial Psychopathology (Ahmed AG, Heigh LM, Ramachandran KV) (522)

polypharmacy
Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution (Procyshyn RM, Kennedy NB, Tse G, Thompson B) (334)

population-based rates
Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates (Brownell MD, Yogendran MS) (264)

populations particulières
Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

positron emission tomography
Neuroimaging studies of antisocial behaviour (Bassarath L) (728)

postnatal
Pre-, peri-, and postnatal trauma in subjects with attention-deficit hyperactivity disorder (Zappitelli M, Pinto T, Grizenko N) (542)

postpartum
The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

postpartum depression
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

poststroke depression
Psychosocial risk factors in poststroke depression: a systematic review (Ouimet MA, Primeau F, Cole MG) (819)

posttraumatic stress disorder
Posttraumatic stress disorder, trauma exposure, and the current health of Canadian bus drivers (Vedantham K, Brunet A, Boyer R, Weiss DS, Metzler TJ, Marmar CR) (149)

Treatment of posttraumatic stress disorder with olanzapine [letter] (Prior TI) (182)

Re: Treatment of Posttraumatic Stress Disorder With Olanzapine [letter] (Labbate LA, Douglas S) (182)

Peritraumatic dissociation, acute stress, and early posttraumatic stress disorder in victims of general crime (Birmes P, Carreras D, Ducassé J-L, Charlet J-P, Warner BA, Lauque D, Laurent Schmitt L) (649)

poverty
Moving from the clinic to the community: the alone mothers together program [letter] (Lipman EL, Secord M, Boyle MH) (657)

prefrontal cortex
Neuroimaging studies of antisocial behaviour (Bassarath L) (728)

pregnancy
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy [letter] (Friedman EH) (371)

Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy: response [letter] (Jerome L) (452)

Metamorphosis of delusion of pregnancy [letter] (Battacharyya S, Chaturvedi SK) (561)

The use of electroconvulsive therapy in special patient populations (Rabheru K) (710)

premenstrual dysphoric disorder
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

prenatal
Pre-, peri-, and postnatal trauma in subjects with attention-deficit hyperactivity disorder (Zappitelli M, Pinto T, Grizenko N) (542)

prevalence
Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results (Rowland AS, Umbach DM, Catoe KE, Stallone L, Long S, Rabiner D, Naftel AJ, Panke D, Faulk R, Sandler DP) (931)

prevalence rates
Is schizophrenia on the decline in Canada? (Woogh C) 61

prevention
Effective interventions for children and adolescents with conduct disorder (Frick PJ) (597)

prison suicides
What was the relevance of previous suicidal behaviour in prison suicides? [letter] (Fruehwald S, Eher R, Frottier P) (763)

problem gambling
Epidemiology of problem gambling in Prince Edward Island: a Canadian microcosm? (Doiron JP, Nicki RM) (413)

A profile of Canadian adults seeking treatment for gambling problems and comparisons with adults entering an alcohol treatment program (Wiebe J, Cox BJ) (418)

prodrome
The pharmacologic treatment of the early phase of first-episode psychosis in youths (Walter G, Wiltshire C, Anderson J, Storm V) (803)

prolactin
Antipsychotic drugs and obesity: is prolactin involved? (Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejìas MA, Hernàndez L) (829)

protective factors
Conduct disorder: a biopsychosocial review (Bassarath L) (609)

psychiatric inpatients
Polydipsia, psychosis, and familial psychopathology (Ahmed AG, Heigh LM, Ramachandran KV) (522)

psychiatric case register
Is schizophrenia on the decline in Canada? (Woogh C) 61

psychiatric disability
Economic impacts of supported employment for Persons With Severe Mental Illness (Latimer EA) (496)

psychiatric genetics
Genetic counselling for schizophrenia in the era of molecular genetics (Hodgkinson KA, Murphy J, O’Neill S, Brzustowicz L, Bassett AS) (123)

Genetic insights into schizophrenia (Bassett AS, Chow EWC, Waterworth DM, Brzustowicz L) (131)

Psychiatric genetics in the 21st century [editorial] (Bassett AS) 121

psychiatrist
Predictors of success and satisfaction in the practice of psychiatry: a preliminary follow-up study (Garfinkel PE, Bagby RM, Schuller DR, Williams CC, Dickens SE, Dorian B) (835)

psychological trauma
Posttraumatic stress disorder, trauma exposure, and the current health of Canadian bus drivers (Vedantham K, Brunet A, Boyer R, Weiss DS, Metzler TJ, Marmar CR) (149)

psychopathology
Polydipsia, psychosis, and familial psychopathology (Ahmed AG, Heigh LM, Ramachandran KV) (522)

psychose
Schizophrénie et psychothérapies cognitivo-comportementales (Abdel-Baki A, Nicole L) (511)

psychoses
Introduction à la psychiatrie génétique : progrès vers la découverte des gènes de susceptibilité aux troubles psychiatriques (Roy M-A, Mérette C, Maziade M) (52)

psychosis
Treating psychosis: is there more to early intervention than intervening early? (Malla AM, Norman RMG) (645)

Obsessive-compulsive disorder and psychosis (Ganesan V, Kumar TCR, Khanna S) (750)

psychosocial
Psychosocial risk factors in poststroke depression: a systematic review (Ouimet MA, Primeau F, Cole MG) (819)

psychosomatics
Posttraumatic Stress disorder, trauma exposure, and the current health ofCanadian bus drivers (Vedantham K, Brunet A, Boyer R, Weiss DS, Metzler TJ, Marmar CR) (149)

psychostimulants
Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates (Brownell MD, Yogendran MS) (264)

psychothérapie cognitive
Schizophrénie et psychothérapies cognitivo-comportementales (Abdel-Baki A, Nicole L) (511)

psychothérapie
Schizophrénie et psychothérapies cognitivo-comportementales (Abdel-Baki A, Nicole L) (511)

Lignes directrices cliniques du traitement des troubles dépressifs (Association des psychiatres du Canada, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

psychothérapie cognitivo-béhaviorale Schizophrénie et psychothérapies cognitivo-comportementales (Abdel-Baki A, Nicole L) (511)

psychothérapie cognitivo-comportementale
Schizophrénie et psychothérapies cognitivo-comportementales (Abdel-Baki A, Nicole L) (511)

psychotherapy
Clinical guidelines for the treatment of depressive disorders [supplement] (The Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments) (1S-92S)

public attitudes
Community attitudes toward people with schizophrenia (Stuart H, Arboleda-Flórez J) (245)